Bio fabrication of galactomannan capped silver nanoparticles to apprehend Ehrlich ascites carcinoma solid tumor in mice

Autor: HP, Syama, BS, Unnikrishnan, J, Sreekutty, MG, Archana, Joseph, Manu M, GU, Preethi, KS, Anusree, PL, Reshma, R, Shiji, TT, Sreelekha

Publikováno v: In Journal of Drug Delivery Science and Technology October 2022 76

Molecular Markers with Predictive and Prognostic Relevance in Lung Cancer.

Autor: Rose-James, Alphy¹, TT, Sreelekha¹ lekhasree64@yahoo.co.in

Publikováno v: Lung Cancer International. 2012, p1-12. 12p. 1 Diagram, 2 Graphs.

Corrigendum to "Anticancer activity of galactoxyloglucan polysaccharide-conjugated doxorubicin nanoparticles: Mechanistic insights and interactome analysis" [Eur. J. Pharm. Biopharm. 93 (2015) 183-195].

Autor: Joseph MM; Laboratory of Biopharmaceuticals and Nanomedicine, Division of Cancer Research, Regional Cancer Centre, Trivandrum, Kerala, India., Aravind SR; Laboratory of Biopharmaceuticals and Nanomedicine, Division of Cancer Research, Regional Cancer Centre, Trivandrum, Kerala, India., George SK; Department of Hematopathology, UT MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA., Pillai RK; Department of Pathology, Regional Cancer Centre, Trivandrum, Kerala, India., Mini S; Department of Biochemistry, University of Kerala, Trivandrum, Kerala, India., Sreelekha TT; Laboratory of Biopharmaceuticals and Nanomedicine, Division of Cancer Research, Regional Cancer Centre, Trivandrum, Kerala, India. Electronic address: ttsreelekha@gmail.com.

Publikováno v: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2021 Apr; Vol. 161, pp. 1-3. Date of Electronic Publication: 2021 Feb 09.

Folic acid-appended galactoxyloglucan-capped iron oxide nanoparticles as a biocompatible nanotheranostic agent for tumor-targeted delivery of doxorubicin.

Autor: Unnikrishnan BS; Laboratory of Biopharmaceuticals and Nanomedicine, Division of Cancer Research, Regional Cancer Centre (Research Centre, University of Kerala), Thiruvananthapuram 695011, Kerala, India., Sen A; Radiodiagnosis Department, Regional Cancer Centre (Research Centre, University of Kerala), Thiruvananthapuram 695011, Kerala, India., Preethi GU; Laboratory of Biopharmaceuticals and Nanomedicine, Division of Cancer Research, Regional Cancer Centre (Research Centre, University of Kerala), Thiruvananthapuram 695011, Kerala, India., Joseph MM; Chemical Sciences & Technology Division (CSTD), Organic Chemistry Section, CSIR- National Institute for Interdisciplinary Science & Technology (CSIR-NIIST), Thiruvananthapuram 695019, Kerala, India., Maya S; Laboratory of Biopharmaceuticals and Nanomedicine, Division of Cancer Research, Regional Cancer Centre (Research Centre, University of Kerala), Thiruvananthapuram 695011, Kerala, India., Shiji R; Laboratory of Biopharmaceuticals and Nanomedicine, Division of Cancer Research, Regional Cancer Centre (Research Centre, University of Kerala), Thiruvananthapuram 695011, Kerala, India., Anusree KS; Laboratory of Biopharmaceuticals and Nanomedicine, Division of Cancer Research, Regional Cancer Centre (Research Centre, University of Kerala), Thiruvananthapuram 695011, Kerala, India., Sreelekha TT; Laboratory of Biopharmaceuticals and Nanomedicine, Division of Cancer Research, Regional Cancer Centre (Research Centre, University of Kerala), Thiruvananthapuram 695011, Kerala, India. Electronic address: sreelekhatt@rcctvm.gov.in.

Publikováno v: International journal of biological macromolecules [Int J Biol Macromol] 2021 Jan 31; Vol. 168, pp. 130-142. Date of Electronic Publication: 2020 Dec 02.

Self-assembled drug loaded glycosyl-protein metal nanoconstruct: Detailed synthetic procedure and therapeutic effect in solid tumor treatment.

Autor: Unnikrishnan BS; Laboratory of Biopharmaceuticals and Nanomedicine, Division of Cancer Research, Regional Cancer Centre (Research Centre, University of Kerala), Thiruvananthapuram, 695011, Kerala, India., Maya S; Laboratory of Biopharmaceuticals and Nanomedicine, Division of Cancer Research, Regional Cancer Centre (Research Centre, University of Kerala), Thiruvananthapuram, 695011, Kerala, India., Preethi GU; Laboratory of Biopharmaceuticals and Nanomedicine, Division of Cancer Research, Regional Cancer Centre (Research Centre, University of Kerala), Thiruvananthapuram, 695011, Kerala, India., Anusree KS; Laboratory of Biopharmaceuticals and Nanomedicine, Division of Cancer Research, Regional Cancer Centre (Research Centre, University of Kerala), Thiruvananthapuram, 695011, Kerala, India., Reshma PL; Laboratory of Biopharmaceuticals and Nanomedicine, Division of Cancer Research, Regional Cancer Centre (Research Centre, University of Kerala), Thiruvananthapuram, 695011, Kerala, India., Archana MG; Laboratory of Biopharmaceuticals and Nanomedicine, Division of Cancer Research, Regional Cancer Centre (Research Centre, University of Kerala), Thiruvananthapuram, 695011, Kerala, India., Kaustabh MK; Chemical Sciences & Technology Division (CSTD), Organic Chemistry Section, CSIR- National Institute for Interdisciplinary Science & Technology (CSIR-NIIST), Thiruvananthapuram, 695019, Kerala, India., Sreelekha TT; Laboratory of Biopharmaceuticals and Nanomedicine, Division of Cancer Research, Regional Cancer Centre (Research Centre, University of Kerala), Thiruvananthapuram, 695011, Kerala, India. Electronic address: sreelekhatt@rcctvm.gov.in.

Publikováno v: Colloids and surfaces. B, Biointerfaces [Colloids Surf B Biointerfaces] 2020 Sep; Vol. 193, pp. 111082. Date of Electronic Publication: 2020 Apr 29.